发明名称 TRIAZINE COMPOUND AND PHARMACEUTICAL APPLICATION THEREOF
摘要 PROBLEM TO BE SOLVED: To provide a compound having mPGES-1 inhibiting activity and useful for the prevention or treatment of a disease, such as pain, rheumatism, osteoarthritis, fever, Alzheimer disease, multiple sclerosis, arterial sclerosis, glaucoma, ocular hypertension, ischemic retinal disease, systemic scleroderma, and malignant tumor such as colon cancer.SOLUTION: A compound represented by the formula [I] or pharmaceutically acceptable salts thereof. [In the formula each symbol is as defined in the specifications.]
申请公布号 JP2015172039(A) 申请公布日期 2015.10.01
申请号 JP20150030157 申请日期 2015.02.19
申请人 JAPAN TOBACCO INC 发明人 NAGAMORI HIROMASA;MITANI IKUO;YAMASHITA MASAKI;HOTTA TAKAHIRO;NAKAGAWA YUICHI;UEDA MASATOSHI
分类号 C07D251/22;A61K31/53;A61K45/00;A61P9/10;A61P17/00;A61P19/02;A61P25/00;A61P25/04;A61P25/28;A61P27/02;A61P27/06;A61P29/00;A61P35/00;A61P43/00;C07D401/12;C07D403/10;C07D403/12;C07D405/12 主分类号 C07D251/22
代理机构 代理人
主权项
地址